Aceto sells generic conjunctivitis medicine
Aceto announced it had begun selling a generic version of Patanol, which is used to treat conjunctivitis. Credit: Barry Sloan
Aceto Corp. has begun selling a generic medicine to treat conjunctivitis.
The Port Washington-based manufacturer of drugs and chemicals said on Monday it has launched olopatadine hydrochloride 0.1 percent ophthalmic solution, a generic version of Patanol from Alcon Inc.
The drug introduction, by Aceto’s Rising Pharmaceuticals division, comes as the patent expires on Patanol.
Sales of the medicine from all manufacturers totaled about $223 million per year, according to data provider IMS Health.
Aceto executives said they expect “six or more generic competitors will enter the market at or around the same time as Rising.”
Out East with Doug Geed: Wine harvests, a fish market, baked treats and poinsettias NewsdayTV's Doug Geed visits two wineries and a fish market, and then it's time for holiday cheer, with a visit to a bakery and poinsettia greenhouses.
Out East with Doug Geed: Wine harvests, a fish market, baked treats and poinsettias NewsdayTV's Doug Geed visits two wineries and a fish market, and then it's time for holiday cheer, with a visit to a bakery and poinsettia greenhouses.
